These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23616122)

  • 61. A local basis for progesterone action during mammary tumorigenesis - no longer RANK and file.
    Petrie WK; Hovey RC
    Breast Cancer Res; 2011 Jan; 13(1):301. PubMed ID: 21345282
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mapping hormone-regulated cell-cell interaction networks in the human breast at single-cell resolution.
    Murrow LM; Weber RJ; Caruso JA; McGinnis CS; Phong K; Gascard P; Rabadam G; Borowsky AD; Desai TA; Thomson M; Tlsty T; Gartner ZJ
    Cell Syst; 2022 Aug; 13(8):644-664.e8. PubMed ID: 35863345
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Finally! A model for progesterone receptor action in normal human breast.
    Lydon JP; Edwards DP
    Endocrinology; 2009 Jul; 150(7):2988-90. PubMed ID: 19549883
    [No Abstract]   [Full Text] [Related]  

  • 64. RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.
    Nolan E; Vaillant F; Branstetter D; Pal B; Giner G; Whitehead L; Lok SW; Mann GB; ; Rohrbach K; Huang LY; Soriano R; Smyth GK; Dougall WC; Visvader JE; Lindeman GJ
    Nat Med; 2016 Aug; 22(8):933-9. PubMed ID: 27322743
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk.
    Rajaram RD; Buric D; Caikovski M; Ayyanan A; Rougemont J; Shan J; Vainio SJ; Yalcin-Ozuysal O; Brisken C
    EMBO J; 2015 Mar; 34(5):641-52. PubMed ID: 25603931
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Endocrine hormones and local signals during the development of the mouse mammary gland.
    Brisken C; Ataca D
    Wiley Interdiscip Rev Dev Biol; 2015; 4(3):181-95. PubMed ID: 25645332
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Hyaluronic acid prevents immunosuppressive drug-induced ovarian damage via up-regulating PGRMC1 expression.
    Zhao G; Yan G; Cheng J; Zhou X; Fang T; Sun H; Hou Y; Hu Y
    Sci Rep; 2015 Jan; 5():7647. PubMed ID: 25558795
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Modulation of Cytokine Production by the Dydrogesterone Metabolite Dihydrodydrogesterone.
    Raghupathy R; Al-Azemi M
    Am J Reprod Immunol; 2015 Nov; 74(5):419-26. PubMed ID: 26250154
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response.
    Sflomos G; Dormoy V; Metsalu T; Jeitziner R; Battista L; Scabia V; Raffoul W; Delaloye JF; Treboux A; Fiche M; Vilo J; Ayyanan A; Brisken C
    Cancer Cell; 2016 Mar; 29(3):407-422. PubMed ID: 26947176
    [TBL] [Abstract][Full Text] [Related]  

  • 70. RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase.
    Hu H; Wang J; Gupta A; Shidfar A; Branstetter D; Lee O; Ivancic D; Sullivan M; Chatterton RT; Dougall WC; Khan SA
    Breast Cancer Res Treat; 2014 Aug; 146(3):515-23. PubMed ID: 25007964
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An ex vivo model to study hormone action in the human breast.
    Sflomos G; Shamsheddin M; Brisken C
    J Vis Exp; 2015 Jan; (95):e52436. PubMed ID: 25590412
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
    Ogba N; Manning NG; Bliesner BS; Ambler SK; Haughian JM; Pinto MP; Jedlicka P; Joensuu K; Heikkilä P; Horwitz KB
    Breast Cancer Res; 2014 Dec; 16(6):489. PubMed ID: 25475897
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response.
    Sikora MJ; Cooper KL; Bahreini A; Luthra S; Wang G; Chandran UR; Davidson NE; Dabbs DJ; Welm AL; Oesterreich S
    Cancer Res; 2014 Mar; 74(5):1463-74. PubMed ID: 24425047
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Membrane progesterone receptors in reproduction and cancer.
    Valadez-Cosmes P; Vázquez-Martínez ER; Cerbón M; Camacho-Arroyo I
    Mol Cell Endocrinol; 2016 Oct; 434():166-75. PubMed ID: 27368976
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Physiology, production and action of progesterone.
    Taraborrelli S
    Acta Obstet Gynecol Scand; 2015 Nov; 94 Suppl 161():8-16. PubMed ID: 26358238
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of the RANK/RANKL pathway in breast cancer.
    Kiesel L; Kohl A
    Maturitas; 2016 Apr; 86():10-6. PubMed ID: 26921922
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 90 YEARS OF PROGESTERONE: Progesterone receptor signaling in the normal breast and its implications for cancer.
    Brisken C; Scabia V
    J Mol Endocrinol; 2020 Jul; 65(1):T81-T94. PubMed ID: 32508307
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comment on "Progesterone/RANKL is a major regulatory axis in the human breast".
    Wang J; Gupta A; Hu H; Chatterton RT; Clevenger CV; Khan SA
    Sci Transl Med; 2013 Dec; 5(215):215le4. PubMed ID: 24337478
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis.
    Pellegrini P; Cordero A; Gallego MI; Dougall WC; Muñoz P; Pujana MA; Gonzalez-Suarez E
    Stem Cells; 2013 Sep; 31(9):1954-65. PubMed ID: 23766243
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Is There a Special Role for Ovarian Hormones in the Pathogenesis of Lobular Carcinoma?
    Flaherty RL; Sflomos G; Brisken C
    Endocrinology; 2024 Mar; 165(5):. PubMed ID: 38551031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.